Zoledronic acid safety and efficacy over 5 years in postmenopausal osteoporosis

Devogelaer, J.-P., Burckhardt, P., Meunier, P., Kaufman, J. M., Lippuner, K., Body, J. J., Samsioe, G., Felsenberg, D., Brown, J., Garnero, P., Sanna, L., Ortmann, C. E., Krasnow, J., Eriksen, E., Fashola, T. F., & Trechsel, U. (2006). Zoledronic acid safety and efficacy over 5 years in postmenopausal osteoporosis. Osteoporosis International : with other metabolic bone diseases, 17, S213-S213. https://hdl.handle.net/2078.5/139415 (Original work published 2006)